Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline. In this video, Kaiser Health News details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to these treatments.
For more information on drug pricing issues, check out this chart and these videos:
This story can be republished for free (details).Tracking Who Makes Money On A Brand-Name Drug
Sounds Like A Good Idea? Regulating Drug Prices
KHN also offers other videos examining hot topics such as selling insurance across state lines, high-risk insurance pools, Medicare’s observation care status and how the health law could be disassembled through the congressional budget reconciliation process.
This story was produced by Kaiser Health News, an editorially independent program of the Kaiser Family Foundation.
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on X (Opens in new window) X
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print
- Republish This Story
Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.